Lobbying Relationship

Client

ADVANCED LIFE SCIENCES

More records

Lobbying firm

POLICY DIRECTIONS INC.

More records

  • FDA regulatory pathway for new antibiotic medicines.
  • Biomedical Advanced Research and Development Authority (BARDA) - development of therapeutic counter-measurers of bioterrorism.

Duration: to

General Issues: Medical/Disease Research/Clinical Labs, Health Issues

Spending: about $160,000 (But it's complicated. Here's why.)

Agencies lobbied since 2009: House of Representatives, U.S. Senate, Food & Drug Administration (FDA), Health & Human Services - Dept of (HHS)

Bills mentioned

H.R.2400: Strategies to Address Antimicrobial Resistance Act

Sponsor: Jim Matheson (D-Utah)

Show All Mentioned Bills

Lobbyists

Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.

Lobbyist Covered positions?
FRANKIE L. TRULL n/a
STEPHEN MICHAEL n/a

Disclosures Filed

Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.

Termination
Q1 Report
Q4 Report
Amendment
Q3 Report
Q2 Report
Q1 Report
Q4 Report
Q3 Report
Registration

Source: Clerk of the U.S. House of Representatives and Secretary of the Senate

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print Google News logo Google_NewsInitiative_Lockup_FullColor RSS Search Search Twitter WhatsApp Resolving differences Check Building Arrow right Info circle Oops OOPS Pencil File text Bars Search Close Cogs Filter Compare Revolving Door Info card Activity Member menu Globe Document External link Quote News Calendar No Vote
Current site Current page